EXAGEN
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen’s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. Exagen was established in 2002 and is headquartered in Vista, California.
EXAGEN
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical
Founded:
2002-01-01
Address:
Vista, California, United States
Country:
United States
Website Url:
http://www.exagen.com
Total Employee:
101+
Status:
Active
Contact:
888-452-1522
Email Addresses:
[email protected]
Total Funding:
322.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Debt - Exagen
J. Hunt Holdings
J. Hunt Holdings investment in Venture Round - Exagen
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Venture Round - Exagen
Sun Mountain Capital
Sun Mountain Capital investment in Venture Round - Exagen
Tullis Health Investors
Tullis Health Investors investment in Venture Round - Exagen
Innovatus Capital Partners
Innovatus Capital Partners investment in Debt Financing - Exagen
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Debt Financing - Exagen
Tullis Health Investors
Tullis Health Investors investment in Debt Financing - Exagen
Sun Mountain Capital
Sun Mountain Capital investment in Debt Financing - Exagen
CRG
CRG investment in Debt Financing - Exagen
Official Site Inspections
http://www.exagen.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: 36.42.202.35.bc.googleusercontent.com
- IP address: 35.202.42.36
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Exagen"
Exagen - Crunchbase Company Profile & Funding
Exagen’s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. …See details»
Leadership – Exagen Inc.
Leadership and Board of DirectorsJohn Aballi President & CEOJohn Aballi has served as President and CEO since October 2022. He most recently served as SVP, GM, Urology and CLIA COO for Veracyte, a San Francisco based molecular diagnostic company. In this role, he maintained P&L responsibility for the business unit, ultimately expanding the urology franchise …See details»
Working At Exagen: Company Overview and Culture - Zippia
May 18, 2020 We calculated Exagen's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Exagen's workforce. Exagen has 181 employees. 55% of Exagen employees are women, while 45% are men. The most common ethnicity at Exagen is White (44%). 34% of Exagen employees are Hispanic or Latino.See details»
Exagen Inc. - Wikidata
Clinical laboratory company. This page was last edited on 18 November 2024, at 19:34. All structured data from the main, Property, Lexeme, and EntitySchema namespaces is available under the Creative Commons CC0 License; text in the other namespaces is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply.By using this …See details»
Exagen Inc. and Johns Hopkins University Announce License …
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical ...See details»
Exagen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Exagen has 1 employees at their 1 location and $52.55 m in annual revenue in FY 2023. See insights on Exagen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Exagen Group - Crunchbase Company Profile & Funding
Exagen Group may be growing as it has recently received approval for a 20MW energy storage facility, which indicates an expansion of its operations in the renewable energy sector. The green light for this new facility suggests that the company is actively investing in its infrastructure to support the growing demand for renewable energy solutions.See details»
| Exagen
The Investor Relations website contains information about Exagen's business for stockholders, potential investors, and financial analysts.See details»
Careers - Exagen Inc.
Exagen CareersCareersWho We AreAt Exagen, we are constantly pushing for new discoveries in the clinical laboratory. Our focus and dedication to the rheumatology space allows for a deep expertise in the development of advanced testing to aid healthcare providers and their patients throughout the continuum of care. Based in Vista, California, we work hard knowing that our …See details»
Exagen Inc. - AnnualReports.com
Exagen Inc. reports have an aggregate usefulness score of 4.8 based on 142 reviews. Exagen Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) View 2022 ESG …See details»
Annual Reports - Exagen
May 2, 2024 The Investor Relations website contains information about Exagen's business for stockholders, potential investors, and financial analysts.See details»
Exagen Announces Appointment of John Aballi as CEO
Oct 17, 2022 The Exagen Board has appointed Mr. Aballi as CEO, President, and a member of the Board. Mr. Aballi is an executive with a broad range of experience in growth-stage companies in the clinical ...See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 …
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full ...See details»
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the …
Jan 19, 2023 Exagen is a patient focused, discovery driven organization built on the success of AVISE testing and is investing in its product pipeline to support patients throughout their autoimmune diagnosis and treatment journeys. The goal at Exagen is to assist patients, physicians, and payors by enabling precision medicine.See details»
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises …
May 13, 2024 Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.See details»
Autoimmune Disease Testing Lab - Life Sciences Company
About Exagen Inc. Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Our portfolio of innovative products enable timely differential diagnosis, prognosis, management, and optimization of therapeutic intervention.See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 …
Dec 31, 2023 CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2023. Financial Highlights: Record total revenue of $52.5 million for the full-year 2023, and total revenue of $13.8 million for the …See details»
Exagen (XGN) Earnings Date and Reports 2025 - MarketBeat
Nov 8, 2024 Exagen issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.28, which topped analysts' consensus estimates of -$0.30 by $0.02. Quarterly revenue was reported to be $12.51 million, below analyst estimates of $13.55 million.See details»
Exagen’s Proprietary Biomarker Technology Enables Physicians to …
Exagen and collaborators spent five years validating the Avise CTD test (the name refers to connective tissue disease) and it has been on the market since 2012. ... “The proud men and women of Exagen,” he says, “built this organization to tackle a disorder that is recognized by healthcare providers as one of the most difficult to diagnose ...See details»